| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0163-7258(97)00006-5 |
| P698 | PubMed publication ID | 9352588 |
| P2093 | author name string | Seeger W | |
| Feuerstein TJ | |||
| P2860 | cites work | Cloning of a delta opioid receptor by functional expression | Q28213132 |
| Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? | Q69449361 | ||
| Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level | Q69727957 | ||
| Endogenous agonists may change the concentration-response curves of exogenous agonists: source of quantitative information about the endogenous tone | Q69904009 | ||
| 5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex | Q70674112 | ||
| A venom peptide with a novel presynaptic blocking action | Q71003270 | ||
| Age-dependent changes in voltage-gated calcium channels and ATP-dependent potassium channels in fisher 344 rats | Q71817520 | ||
| Nitric oxide alters proenkephalin and prodynorphin gene expression in hippocampal granule cells | Q72829432 | ||
| Pre- and postsynaptic muscarinic receptors in surgical samples from human cerebral cortex | Q72922596 | ||
| Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist | Q28280800 | ||
| Substance P and substance P receptor histochemistry in human neurodegenerative diseases | Q28298522 | ||
| Norbinaltorphimine: antagonist profile at kappa opioid receptors | Q34553533 | ||
| Preferential release of newly synthesized 3H-acetylcholine from rat cerebral cortex slices in vitro | Q35600751 | ||
| Effects of cations on binding, in membrane suspensions, of various opioids at mu-sites of rabbit cerebellum and kappa-sites of guinea-pig cerebellum | Q35754763 | ||
| Acetylcholine release is modulated by different opioid receptor types in different brain regions and species | Q37878939 | ||
| Psychopharmacological strategies in the search for cognition enhancers | Q37921782 | ||
| Involvement of hormonal and neuromodulatory systems in the regulation of memory storage | Q38342619 | ||
| Modulation of neurotransmitter release by presynaptic autoreceptors | Q38357259 | ||
| Acetylcholine and Alzheimer's disease | Q39524855 | ||
| High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis | Q39852853 | ||
| Neurophysiological effects of capsaicin | Q40075887 | ||
| Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation | Q40145746 | ||
| Statistical Aspects of Comparative Bioavailability Trials | Q41036133 | ||
| Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor | Q41083646 | ||
| The autoinhibitory feedback control of acetylcholine release in human neocortex tissue | Q41124861 | ||
| A comparison of extracellular and intracellular recordings from medial septum/diagonal band neurons in vitro | Q41135096 | ||
| The release of labelled acetylcholine and choline from cerebral cortical slices stimulated electrically | Q42035444 | ||
| Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. | Q42117930 | ||
| Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain | Q42467365 | ||
| Activity of identified cortically projecting and other basal forebrain neurones during large slow waves and cortical activation in anaesthetized rats | Q42501341 | ||
| Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex | Q43536400 | ||
| The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors | Q44336937 | ||
| No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids | Q44338966 | ||
| Opioid receptor-mediated control of acetylcholine release in human neocortex tissue | Q44344275 | ||
| Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit | Q44344368 | ||
| Microinjection of dynorphin into the hippocampus impairs spatial learning in rats | Q44858074 | ||
| New insights into receptor theory, as provided by an artificial partial agonist made-to-measure | Q48099991 | ||
| Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release | Q48289098 | ||
| [D-Pen2,D-Pen5]enkephalin (DPDPE): a delta-selective enkephalin with low affinity for mu 1 opiate binding sites | Q48300396 | ||
| Mathematical modelling and quantification of the autoinhibitory feedback control of noradrenaline release in brain slices | Q48340850 | ||
| Substance P-immunoreactive neurons in the neocortex of the rat: a subset of the glutamic acid decarboxylase-immunoreactive neurons | Q48364833 | ||
| The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia | Q48422201 | ||
| 5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release | Q48474428 | ||
| Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation | Q48486635 | ||
| Selective impairment of declarative memory following stimulation of dentate gyrus granule cells: a naloxone-sensitive effect | Q48621633 | ||
| Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients | Q48864195 | ||
| Observations on the brains of demented old people | Q48896308 | ||
| Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex | Q48950336 | ||
| 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease | Q49157195 | ||
| A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. | Q52026922 | ||
| Naloxone enhancement of memory. | Q52106231 | ||
| Opiate antagonists improve spatial memory. | Q52214793 | ||
| 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue | Q59077987 | ||
| Substance P release from spinal cord slices by capsaicin | Q59345300 | ||
| Selective agonists for substance P and neurokinin receptors | Q69008701 | ||
| Release of substance P from the cat spinal cord | Q69022182 | ||
| Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat | Q69357540 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 333-347 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer's disease | |
| P478 | volume | 74 |
| Q31818154 | A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia |
| Q36681956 | Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation |
| Q35045220 | Cannabinoid CB1 receptor‐mediated inhibition of hippocampal acetylcholine release is preserved in aged mice |
| Q73824944 | Evaluation of the potentiometric detection of acetylcholine and other neurotransmitters in capillary electrophoresis |
| Q41582787 | How to express an effect mean as percentage of a control mean? |
| Q48100392 | Modulation of acetylcholine and 5-hydroxytryptamine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts containing cholinergic and/or serotonergic neurons. |
| Q42603788 | Nerve growth factor differentially affects spatial and recognition memory in aged rats |
| Q42505129 | Parvalbumin-containing interneurons of the human cerebral cortex express nicotinic acetylcholine receptor proteins |
| Q34190355 | Substance P and Substance P Receptor Antagonists in the Pathogenesis and Treatment of Affective Disorders |
| Q44351771 | delta 1-Opioid receptor-mediated control of acetylcholine (ACh) release in human neocortex slices |
Search more.